Mvt-101
Mvt-101 is a hexapeptide-based inhibitor of HIV-1 protease. Mvt-101 is also reduced-peptide-bond inhibitor. Mvt-101 inhibits reproduction of the HIV virus by blocking protease action[1].
Product Specifications
CAS Number
125552-93-4
UNSPSC
12352209
Target
HIV Protease
Type
Peptides
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mvt-101.html
Solubility
10 mM in DMSO
Smiles
CC(N[C@@H]([C@H](O)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCC)CN[C@@H](CCCC)C(N[C@@H](CCC(N)=O)C(N[C@H](C(N)=O)CCCNC(N)=N)=O)=O)=O)=O)=O
Molecular Formula
C35H67N11O8
Molecular Weight
769.98
References & Citations
[1]Torbeev VY, et al. Protein conformational dynamics in the mechanism of HIV-1 protease catalysis. Proc Natl Acad Sci USA. 2011 Dec 27;108 (52) :20982-7.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog